The government is yet to decide on which segment of beneficiaries this new vaccine would be administered.

Millions have rolled up their sleeves for the COVID-19 vaccine, but why haven't they rolled up their pants legs instead? Why do we get most...

Covaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is be...

"The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommend...

Most vaccines are administered by injection through intramuscular or subcutaneous route.

Health Secretary J Radhakrishnan, who inspected the administering of the second dose to healthcare workers at the Government Rajiv Gandhi G...

"Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 cl...

A national expert group is talking to public and private sector entities in the pharmaceutical sector, food processing industry and agro bu...

If proven effective, this process could help more people get vaccinated and make Covaxin cheaper as it requires lesser amount of vaccine. I...

Zydus Cadila's move to begin human trials of its indigenously developed vaccine candidate for COVID-19 is an important milestone for an 'At...

Krishna M Ella, a molecular biologist and chairman and managing director of the Bharat Biotech, spoke to TOI's Surendra Singh in an exclusi...

The spectrum includes bleeding wound sealants, super absorptive dressings and glycerated salines, all of which can save lives in the event ...

Novartis’ Voveran 1ml and Themis' Aquadol have competed with Troikaa’s own injection to manage pain, Dynapar AQ, since their launch in 2013.